Ctssem1Narl
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Ctssem1Narl |
| Name: |
cathepsin S; endonuclease-mediated mutation 1, National Laboratory Animal Center |
| MGI ID: |
MGI:6818656 |
| Gene: |
Ctss Location: Chr3:95434097-95463714 bp, + strand Genetic Position: Chr3, 40.74 cM
|
| Alliance: |
Ctssem1Narl page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Null/knockout) |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: CRISPR/Cas9 technology introduced several mutations (atgcccctggtg to atgTGActAgtg), including a stop codon, in exon 2 right after the transcription start site to inhibit RNA and protein expression.
(J:314270)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Ctss Mutation: |
33 strains or lines available
|
|
| Original: |
J:314270 Chen SJ, et al., Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy. Theranostics. 2021;11(10):4672-4687 |
| All: |
1 reference(s) |
|